KINETA
- Pharmaceutical Preparations
- Seattle, Washington
Compensation history
Top executives at KINETA received an average of $1M per person in annual compensation from 2014 to 2022.
Average pay of disclosed executives at KINETA
By year
- 2022
RM$3MRichard Peters M.D.Ph.DFormer Chief Executive OfficerSI$2MShawn IadonatoChief Executive Officer and DirectorCP$1MCraig W. PhilipsPresidentDS$879KDevin SmithFormer Senior Vice President, General Counsel and SecretaryMW$837KMichael WyzgaFormer Senior Vice President and Chief Financial OfficerPK$742KPauline KennyGeneral Counsel- 2021
RM$4MRichard Peters M.D.Ph.DFormer Chief Executive OfficerRP$4MRichard PetersPh.D. Chief Executive OfficerCP$3MCraig W. PhilipsPresidentAV$2MAjay VermaFormer Executive Vice President, Head of Research & DevelopmentSI$2MShawn IadonatoChief Executive Officer and DirectorNC$2MN. Anthony ColesChair of the Board of Directors, and former Executive ChairPM$1MPaulash MohsenFormer Chief Business OfficerDS$1MDevin SmithFormer Senior Vice President, General Counsel and SecretaryMW$682KMichael WyzgaFormer Senior Vice President and Chief Financial OfficerPK$473KPauline KennyGeneral Counsel- 2020
MC$3MMeenu ChhabraFormer Chief Executive OfficerMZ$1MMarija ZecevicFormer Chief Commercial OfficerRP$1MRichard PetersChief Executive OfficerSW$784KSheila WilsonFormer Chief Operating OfficerNC$744KN. Anthony ColesExecutive Chair of the Board of DirectorsPM$733KPaulash MohsenChief Business Officer
Executives
We found 17 executives who work or worked at KINETA.
Shawn Iadonato
KINETA
Chief Executive Officer
Craig Philips
KINETA
President
Pauline Kenny
KINETA
General Counsel
Richard MDPhD
KINETA
Chief Executive Officer
Devin Smith
KINETA
General Counsel
Michael Wyzga
KINETA
Chief Financial Officer
Richard Peters
KINETA
Chief Executive Officer
Paulash Mohsen
KINETA
Former Chief Business Officer
News
About KINETA
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address219 Terry Ave. N., Suite 300, Seattle, Washington 98109
- Phone(206) 378-0400
- Fiscal year endDecember 31
- Former names
- YUMANITY THERAPEUTICS, INC.Until December 15, 2022
- PROTEOSTASIS THERAPEUTICS, INC.Until December 15, 2020
- PROTEOSTASIS THERAPEUTICS INCUntil June 1, 2011
Source: SEC filings on April 28, 2023, April 25, 2022, April 22, 2021, April 30, 2019, April 19, 2018, April 27, 2017, and April 29, 2016.